Navigation Links
Taiho Pharmaceutical stellt Zulassungsantrag zur Herstellung und Vermarktung des neuartigen Antitumormittels TAS-102
Date:2/26/2013

pan> und aller Welt als führendes Unternehmen bekannt, das innovative Medikamente zur Behandlung von Krebs entwickelt. Auch außerhalb der Onkologie entwickelt das Unternehmen Qualitätsprodukte zur effektiven Behandlung von Erkrankungen und trägt so zur Verbesserung der Lebensqualität von Patienten bei. Für Taiho Pharmaceutical steht der Kunde stets an erster Stelle. Deshalb beabsichtigt das Unternehmen, auch rezeptfreie Medikamente und Produkte anzubieten, die Menschen bei ihrem Streben nach einem erfüllten und zufriedenstellenden Leben unterstützen. Nähere Informationen zu Taiho Pharmaceutical erhalten Sie auf http://www.taiho.co.jp/english/. Der Präsident des Unternehmens mit Hauptsitz in Tokio ist Masayuki Kobayashi .

Informationen zu Otsuka Holdings Co., Ltd.
Die Otsuka-Gruppe ist ein globaler Konzern mit 156 Healthcare-Unternehmen und fast 40.000 Mitarbeitern. Otsuka Holdings Co., Ltd. ist die Holdinggesellschaft der Gruppe. Die wesentlichen operativen Gesellschaften sind Otsuka Pharmaceutical Co., Ltd.; Otsuka Pharmaceutical Factory, Inc.; Taiho Pharmaceutical Co., Ltd.; Otsuka Warehouse Co., Ltd. und Otsuka Chemical Co., Ltd. Die Gruppe ist in 25 Ländern und Regionen aktiv und in vier Segmenten mit dem gemeinsamen Schwerpunktbereich Gesundheit in verschiedenste Geschäfte involviert: Pharmazeutika, Nutrazeutika, Verbrauchsgüter und sonstige Produktbereiche. Die konzernweite Philosophie der Gruppe „Otsuka-Mitarbeiter entwickeln neue Produkte für eine bessere Gesundheit weltweit" wird durch den konzernweiten ethischen Grundsatz „JISSHO (Umsetzung als Nachweis) und SOZOSEI (Kreativität)" untermauert. Auf diese Weise bemüht sich die Otsuka-Gruppe, einerseits genau die Art von Kultur und Vitalität zu fördern, die für
'/>"/>

SOURCE Taiho Pharmaceutical Co., Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Taiho Pharmaceutical Submits Application for Approval to Manufacture and Market Novel Antitumor Agent TAS-102
2. Taiho Pharmaceutical présente une demande dhomologation pour la fabrication et la commercialisation du nouvel agent antitumoral TAS-102
3. Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102
4. Jazz Pharmaceuticals Reports Full Year And Fourth Quarter 2012 Financial Results
5. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Cowen & Company 33rd Annual Health Care Conference In Boston On March 5, 2013
6. Global Pharmaceutical Industry Trends: Procurement Budgets Stay the Same, Marketing Budgets to Experience Slight Decrease
7. Savient Pharmaceuticals to Hold Fourth Quarter and Year-End 2012 Financial Results Conference Call on Tuesday, March 19, 2013
8. Savara Pharmaceuticals Announces Formation of Clinical Advisory Board
9. Isis Pharmaceuticals Initiates Phase 2 Study Of ISIS-CRP Rx In Patients With Atrial Fibrillation
10. UBM Launches PharmaEvolution.com, an Online Peer-to-Peer Network for Pharmaceutical Industry Professionals
11. Alexza Pharmaceuticals Corporate Presentation to Be Webcast at Three Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... Nonin Medical, a global leader in noninvasive medical monitoring, ... Steve Bucholz will retire May 1. Company founder ... Chief Executive Officer. In addition, Mr. Isaacson will continue ... transition to David Noel , Chief Financial Officer. ... to Nonin Medical,s growth," Mr. Isaacson said. "Under Steve,s ...
(Date:4/17/2015)... R.I , April 17, 2015 CVS ... a conference call on Friday, May 1, 2015, at ... its first quarter financial results. An audio ... through the Investor Relations portion of the CVS Health ... visit http://investors.cvshealth.com . This webcast will be archived ...
(Date:4/17/2015)... ASSESS shows   plasma circulating tumour DNA (ctDNA) ... tumour biopsy   IGNITE supports value of ... AstraZeneca today presented results from two key studies ... for epidermal growth factor receptor (EGFR) mutation status in newly ... clinical practice. [ 1 ] , ...
Breaking Medicine Technology:Nonin Medical's Philip Isaacson Expands CEO Role; President and COO Steve Bucholz to Retire May 1 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 3"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 4
... AUG. 2 Two major studies,published today in The ... pregnant women at risk for preterm delivery who can ... today. In one large multi-center trial led by ... whom had no prior history of preterm birth) who,received ...
... Population of Glioblastoma Patients Expected to Support ... Promising New Approach -, TUSTIN, Calif., Aug. 2 ... stage biopharmaceutical,company developing targeted monoclonal antibodies for the treatment ... the first,patient has been administered Cotara(R) in a new ...
Cached Medicine Technology:Progesterone Therapy and Preterm Birth: More Evidence Helps Identify Women Who Can Benefit 2Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India 2Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India 3Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India 4
(Date:4/19/2015)... Philadelphia, Pennslyvania (PRWEB) April 19, 2015 ... and proved tolerable in a small group of healthy ... (UPCI), partner with UPMC CancerCenter , announced ... (AACR) Annual Meeting in Philadelphia. , The ... clinical trial, which will recruit participants at high risk ...
(Date:4/19/2015)... 2015 New court documents issued by ... that Lipitor lawsuits ( http://www.lipitorlawsuitcenter.com/ ) continue to mount ... District of South Carolina. According to the April 15th ... in the proceeding on behalf of individuals who allegedly ... the cholesterol-lowering statin. This represents an increase of 110 ...
(Date:4/19/2015)... April 19, 2015 Family and friends of ... Brains in Memory of Brad Baddeley event to honor ... Foundation. , Bowling for Brains is cheduled to take place ... Dudley Street in Lincoln, Nebraska. Participants may arrive at 12:30pm ... 3:00pm. , The cost is only $4 per game and ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 Carinsurancequotesinfo.com has ... insurance can cover physical injuries caused by a ... excellent financial coverage for a vehicle. A policy can ... by an accident. Drivers should always carry appropriate coverage ... insurance policy can be bought with several important riders ...
(Date:4/18/2015)... 2015 Review of Ophthalmology magazine and ... for Success’ program for cataract surgeons attending the American ... Diego, where eye surgeon Jeffrey L. Martin, MD will ... Dr. Martin is the Managing Partner of North Shore ... Dr. Martin to lead this year’s discussion on the ...
Breaking Medicine News(10 mins):Health News:Preventing Cancer with Broccoli Sprout Extract 2Health News:Preventing Cancer with Broccoli Sprout Extract 3Health News:Lipitor Lawsuits Mount, as New Court Report Shows More Than 100 Filings Added to Federal Litigation Since March 2Health News:Lipitor Lawsuits Mount, as New Court Report Shows More Than 100 Filings Added to Federal Litigation Since March 3Health News:Lincoln, NE’s Bowling for Brains to benefit Renowned Brain Aneurysm Foundation 2Health News:Lincoln, NE’s Bowling for Brains to benefit Renowned Brain Aneurysm Foundation 3Health News:Auto Insurance Plans Can Cover Physical Injuries Caused By An Accident! 2Health News:Dr. Jeffrey Martin Invited to Share Latest Breakthroughs in Cataract Care During Roundtable Discussion at National 2015 ASCRS Meeting In San Diego 2
... Thursday asked the government, the railway ministry and the Indian ... petition accusing them of supplying unhygienic food to rail passengers.// ... Khetrapal issued notice to the respondents to file their replies ... entrusted with the task of supplying food to passengers on ...
... Society Wolfson Research Professor and inventor of DNA Fingerprinting ... which will be awarded to him later this year. ... Heineken Prize for Biochemistry and Biophysics 2006 by the ... of the discovery of the revolutionary technique. ...
... shake-up of the out of hours health care system in England ... ,The public accounts committee claimed that the new health ... met many key targets. ,In 2004 most GPs had ... which PCTs took over in 90% of cases. ,The ...
... launched by the Cancer Research UK, and its ... take up// drug candidates that pharmaceuticals companies have ... their preclinical studies. By this they plan to ... been shelved by pharmaceutical and biotechnology companies. ...
... and Aberdeen University in Scotland found that women with ... have twins// following in vitro fertilization. They found that ... multiple births after fertility treatment. ,However, the ... protects against birth defects such as spina bifida, does ...
... Embryology Authority show that recently there is a surge ... technology// (ART) in the UK. It is astonishing to ... 34. There is increase in women choosing to delay ... and scientists say that there are long-term risks associated ...
Cached Medicine News:Health News:Inventor of DNA fingerprinting Wins Accolades 2Health News:Cancer Research UK Offers New Hope To Cancer Patients 2Health News:High Levels Of Folic Acid May Increase The Chances Of Twins After IVF 2
... new Vivid i is ... to provide high-performance, full-featured imaging in a ... addresses one of the biggest ... complete, real-time diagnostic information. The new system ...
... CRP test is an immunochromatography based ... is designed for semi-quantitative determination of ... serum or whole blood specimens. The ... or whole blood can be detected ...
The Bio-Quant CK-MB test is an immunochromatography based one step in vitro test. It is designed for qualitative determination of,CK-MB in human serum specimens as an aid in the diagnosis of myocar...
This advanced digital monitor detects the appearance of an irregular heartbeat during measurement and gives a warning signal with your reading. An irregular heartbeat may cause or indicate cardiovasc...
Medicine Products: